Literature DB >> 19228803

An integrative scoring system for ranking SNPs by their potential deleterious effects.

Phil Hyoun Lee1, Hagit Shatkay.   

Abstract

MOTIVATION: Identifying single nucleotide polymorphisms (SNPs) that underlie common and complex human diseases, such as cancer, is of major interest in current molecular epidemiology. Nevertheless, the tremendous number of SNPs on the human genome requires computational methods for prioritizing SNPs according to their potentially deleterious effects to human health, and as such, for expediting genotyping and analysis. As of yet, little has been done to quantitatively assess the possible deleterious effects of SNPs for effective association studies.
RESULTS: We propose a new integrative scoring system for prioritizing SNPs based on their possible deleterious effects within a probabilistic framework. We applied our system to 580 disease-susceptibility genes obtained from the OMIM (Online Mendelian Inheritance in Man) database, which is one of the most widely used databases of human genes and genetic disorders. The scoring results clearly show that the distribution of the functional significance (FS) scores for already known disease-related SNPs is significantly different from that of neutral SNPs. In addition, we summarize distinct features of potentially deleterious SNPs based on their FS score, such as functional genomic regions where they occur or bio-molecular functions that they mainly affect. We also demonstrate, through a comparative study, that our system improves upon other function-assessment systems for SNPs, by assigning significantly higher FS scores to already known disease-related SNPs than to neutral SNPs.

Entities:  

Mesh:

Year:  2009        PMID: 19228803     DOI: 10.1093/bioinformatics/btp103

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  52 in total

1.  Plastin polymorphisms predict gender- and stage-specific colon cancer recurrence after adjuvant chemotherapy.

Authors:  Yan Ning; Armin Gerger; Wu Zhang; Diana L Hanna; Dongyun Yang; Thomas Winder; Takeru Wakatsuki; Melissa J Labonte; Sebastian Stintzing; Nico Volz; Yu Sunakawa; Stefan Stremitzer; Rita El-Khoueiry; Heinz-Josef Lenz
Journal:  Mol Cancer Ther       Date:  2013-10-29       Impact factor: 6.261

2.  Does genetic regulation of IgE begin in utero? Evidence from T(H)1/T(H)2 gene polymorphisms and cord blood total IgE.

Authors:  Xiumei Hong; Hui-Ju Tsai; Xin Liu; Lester Arguelles; Rajesh Kumar; Guoying Wang; Nataliya Kuptsova-Clarkson; Colleen Pearson; Kathryn Ortiz; Anthony Bonzagni; Stephanie Apollon; Lingling Fu; Jacqueline A Pongracic; Robert Schleimer; Patrick G Holt; Howard Bauchner; Xiaobin Wang
Journal:  J Allergy Clin Immunol       Date:  2010-11       Impact factor: 10.793

Review 3.  Phylomedicine: an evolutionary telescope to explore and diagnose the universe of disease mutations.

Authors:  Sudhir Kumar; Joel T Dudley; Alan Filipski; Li Liu
Journal:  Trends Genet       Date:  2011-07-20       Impact factor: 11.639

4.  Single nucleotide polymorphisms of the adult intestinal stem cell marker Lgr5 in primary and metastatic colorectal cancer.

Authors:  Britta Kleist; Li Xu; Christian Kersten; Violetta Seel; Guojun Li; Micaela Poetsch
Journal:  Am J Transl Res       Date:  2012-07-20       Impact factor: 4.060

5.  Regionally clustered ABCC8 polymorphisms in a prospective cohort predict cerebral oedema and outcome in severe traumatic brain injury.

Authors:  Ruchira Menka Jha; Theresa A Koleck; Ava M Puccio; David O Okonkwo; Seo-Young Park; Benjamin E Zusman; Robert S B Clark; Lori A Shutter; Jessica S Wallisch; Philip E Empey; Patrick M Kochanek; Yvette P Conley
Journal:  J Neurol Neurosurg Psychiatry       Date:  2018-04-19       Impact factor: 10.154

6.  Integrin genetic variants and stage-specific tumor recurrence in patients with stage II and III colon cancer.

Authors:  P Bohanes; D Yang; F Loupakis; M J LaBonte; A Gerger; Y Ning; C Lenz; F Lenz; T Wakatsuki; W Zhang; L Benhaim; A El-Khoueiry; R El-Khoueiry; H-J Lenz
Journal:  Pharmacogenomics J       Date:  2014-12-09       Impact factor: 3.550

7.  Genetic dissection of the pre-eclampsia susceptibility locus on chromosome 2q22 reveals shared novel risk factors for cardiovascular disease.

Authors:  Matthew P Johnson; Shaun P Brennecke; Christine E East; Thomas D Dyer; Linda T Roten; J Michael Proffitt; Phillip E Melton; Mona H Fenstad; Tia Aalto-Viljakainen; Kaarin Mäkikallio; Seppo Heinonen; Eero Kajantie; Juha Kere; Hannele Laivuori; Rigmor Austgulen; John Blangero; Eric K Moses
Journal:  Mol Hum Reprod       Date:  2013-02-18       Impact factor: 4.025

8.  Analysis of functional germline polymorphisms for prediction of response to anthracycline-based neoadjuvant chemotherapy in breast cancer.

Authors:  Joanna Szkandera; Gudrun Absenger; Nadia Dandachi; Peter Regitnig; Sigurd Lax; Michael Stotz; Hellmut Samonigg; Wilfried Renner; Armin Gerger
Journal:  Mol Genet Genomics       Date:  2012-08-18       Impact factor: 3.291

9.  Impact of Polymorphic Variations of Gemcitabine Metabolism, DNA Damage Repair, and Drug-Resistance Genes on the Effect of High-Dose Chemotherapy for Relapsed or Refractory Lymphoid Malignancies.

Authors:  Keiji Shinozuka; Hongwei Tang; Roy B Jones; Donghui Li; Yago Nieto
Journal:  Biol Blood Marrow Transplant       Date:  2015-12-29       Impact factor: 5.742

10.  Knowledge-based data analysis comes of age.

Authors:  Michael F Ochs
Journal:  Brief Bioinform       Date:  2009-10-23       Impact factor: 11.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.